This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Thrombopoietin Levels and Platelet Transfusion in Neonates

This study has been completed.
Information provided by:
Christiana Care Health Services Identifier:
First received: October 24, 2007
Last updated: January 16, 2008
Last verified: January 2008
Infants who have low platelets and who require a platelet transfusion are included in this study. Platelet transfusions are routinely given to infants when their platelet count falls below a certain level. The study will look at the amount of platelets transfused. The purpose of the study is to evaluate the effect of platelet transfusions on the level of a protein (thrombopoietin) which is known to help control platelet production.


Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Thrombopoietin Levels Following Platelet Transfusion in Neonates With Thrombocytopenia

Resource links provided by NLM:

Further study details as provided by Christiana Care Health Services:

Primary Outcome Measures:
  • Reduction in TPO levels following platelet transfusion [ Time Frame: Within 36 hours of transfusion ]

Secondary Outcome Measures:
  • Platelet rise following platelet transfusion in 10 mL/kg versus 15 mL/kg. [ Time Frame: Within 36 hours after platelet transfusion ]

Biospecimen Retention:   Samples With DNA
Blood samples were collected pre and post platelet transfusion. Samples included platelet count, thrombopoietin, and platelet factor 4.

Enrollment: 20
Study Start Date: May 2003
Study Completion Date: September 2004
Primary Completion Date: September 2004 (Final data collection date for primary outcome measure)
10 mL/kg platelet transfusion
15 mL / kg platelet transfusion

Detailed Description:

Thrombocytopenia, defined as a platelet count < 150,000/mm3, is a very common hematologic problem in the neonatal period. Multiple etiologies are known to be associated with thrombocytopenia in neonates. Thrombopoietin (TPO) is known to be the central regulator of megakaryocyte and platelet production in adults and infants. However, the role of TPO in neonatal platelet regulation is not well understood. TPO levels have been shown to be higher in neonates with thrombocytopenia, with a decrease in TPO after resolution of the thrombocytopenia. The response of TPO levels in neonates after platelet transfusion has never been studied. In addition, the optimal volume of platelet transfusions has never been studied in neonates. This study will evaluate the response to 2 different volumes of platelet transfusion.

We hypothesize that a decrease in plasma TPO levels will be seen following a platelet transfusion in a population of neonates with thrombocytopenia. We also hypothesize that a platelet transfusion of 15 mL/kg will result in a greater rise in platelet count than a transfusion pf 10 mL/kg of platelets.


Ages Eligible for Study:   up to 6 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Infants who require platelet transfusion

Inclusion Criteria:

  • Preterm infants with thrombocytopenia
  • Decision made by medical team to transfuse with platelets

Exclusion Criteria:

  • Infants with major congenital malformations
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00549484

United States, Delaware
Christiana Hospital
Newark, Delaware, United States, 19718
Sponsors and Collaborators
Christiana Care Health Services
Principal Investigator: Alex Kline, MD Christiana Hospital
Principal Investigator: David A. Paul, MD Christiana Hospital
  More Information

Responsible Party: T. Alex Kline, Christiana Hospital Identifier: NCT00549484     History of Changes
Other Study ID Numbers: CCC#23049
Study First Received: October 24, 2007
Last Updated: January 16, 2008

Keywords provided by Christiana Care Health Services:
Platelet Transfusion
Platelet Factor 4

Additional relevant MeSH terms:
Blood Platelet Disorders
Hematologic Diseases processed this record on August 18, 2017